Results
Sandu Pharmaceuticals Q4 Net Profit at ₹4.34 Lakh
Board approved standalone audited financial results for Q4 and FY ended March 31, 2026, reporting annual net profit of ₹176.61 lakh.
Recommended a final dividend of ₹1 per equity share (10%) for FY 20
